Cargando…
Efficacy and Safety of a Personalized Vitamin D(3) Loading Dose Followed by Daily 2000 IU in Colorectal Cancer Patients with Vitamin D Insufficiency: Interim Analysis of a Randomized Controlled Trial
A personalized vitamin D(3) loading dose has not yet been tested in cancer patients. This interim analysis of the randomized, placebo-controlled VICTORIA trial analyzed the first recruited 74 German adults with nonmetastatic colorectal cancer, a tumor surgery within the past year, and 25-hydroxyvita...
Autores principales: | Kuznia, Sabine, Czock, David, Kopp-Schneider, Annette, Caspari, Reiner, Fischer, Harald, Laetsch, Dana Clarissa, Slavic, Marija, Brenner, Hermann, Schöttker, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658724/ https://www.ncbi.nlm.nih.gov/pubmed/36364809 http://dx.doi.org/10.3390/nu14214546 |
Ejemplares similares
-
Protocol of the VICTORIA study: personalized vitamin D supplementation for reducing or preventing fatigue and enhancing quality of life of patients with colorectal tumor - randomized intervention trial
por: Schöttker, Ben, et al.
Publicado: (2020) -
Prevention of Advanced Cancer by Vitamin D(3) Supplementation: Interaction by Body Mass Index Revisited
por: Brenner, Hermann, et al.
Publicado: (2021) -
Vitamin D(3) Supplementation: Comparison of 1000 IU and 2000 IU Dose in Healthy Individuals
por: Dědečková, Eva, et al.
Publicado: (2023) -
Vitamin D-Binding Protein, Bioavailable, and Free 25(OH)D, and Mortality: A Systematic Review and Meta-Analysis
por: Zhu, Anna, et al.
Publicado: (2022) -
Prevention of Vitamin D deficiency in infancy: daily 400 IU vitamin D is sufficient
por: Mutlu, Gul Yesiltepe, et al.
Publicado: (2011)